Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis.

Source:http://linkedlifedata.com/resource/pubmed/id/8381577

Download in:

View as

General Info

PMID
8381577